Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Protagonist Therapeutics (PTGX) Return on Assets (2017 - 2025)

Protagonist Therapeutics (PTGX) has disclosed Return on Assets for 9 consecutive years, with 0.0% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 41.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, down 41.0% year-over-year, with the annual reading at 0.0% for FY2025, 50.0% down from the prior year.
  • Return on Assets hit 0.0% in Q4 2025 for Protagonist Therapeutics, down from 0.06% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.41% in Q4 2024 to a low of 0.57% in Q1 2023.
  • Historically, Return on Assets has averaged 0.07% across 5 years, with a median of 0.01% in 2022.
  • Biggest five-year swings in Return on Assets: crashed -58bps in 2023 and later soared 90bps in 2024.
  • Year by year, Return on Assets stood at 0.0% in 2021, then plummeted by -70478bps to 0.48% in 2022, then skyrocketed by 52bps to 0.23% in 2023, then soared by 278bps to 0.41% in 2024, then crashed by -100bps to 0.0% in 2025.
  • Business Quant data shows Return on Assets for PTGX at 0.0% in Q4 2025, 0.06% in Q3 2025, and 0.07% in Q2 2025.